HOME >> BIOLOGY >> NEWS
Emory scientists find new prostate cancer suppressor gene

ATLANTA--A gene named ATBF1 may contribute to the development of prostate cancer through acquired mutations and/or loss of expression, according to research at Emory University School of Medicine and its Winship Cancer Institute. The findings were published in the online edition of Nature Genetics on March 6. The Emory research team was led by Jin-Tang Dong, PhD, associate professor in the Winship Cancer Institute. Lead author was postdoctoral fellow Xiaodong Sun, PhD.

Although previous research has suggested that a section of chromosome 16 harbors a tumor suppressor gene in several types of human cancers, the particular gene responsible has not previously been identified. By studying the genes within the section of chromosome 16, the Emory scientists found that ATBF1 was a strong candidate for an important tumor suppressor gene because its function is frequently lost in prostate cancer through gene mutations and/or loss of expression. In addition, ATBF1 was found to inhibit cell growth in culture dishes. A tumor suppressor gene is a gene whose loss of function contributes to the development of cancer.

ATBF1 is a transcription factor (regulator of gene expression) that functions to regulate the expression of other genes. If its function is impaired by mutations or loss of expression, a cell could lose the control of cancer genes. The Myb oncogene, for example, is normally inhibited by ATBF1, but it can be activated if ATBF1 is lost.

"Sporadic cancers often are the result of multiple genetic alterations that accumulate over time," said Dr. Dong, "but only a small number of genes have been shown to undergo these frequent mutations. Because ATBF1 inhibits cell proliferation, frequent acquired mutations that inhibit the gene, such as the ones we found, could lead to a lack of growth control in prostate cancer. Because gene deletion in chromosome 16 is common in many types of cancer, including lung, head and neck, nasopharynx, stomach, breast, and
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
22-Mar-2005


Page: 1 2

Related biology news :

1. New genetic test developed at Emory advances detection and diagnosis of muscular dystrophy
2. Emory scientists develop new map of genetic variation in human genome
3. Hormones may affect how brain listens, Emory study finds
4. Emory scientists discover unique binding method for essential cellular protein ubiquitin
5. Blood conservation strategies take center stage at Emory University Hospital forum
6. NIH awards Georgia Tech/Emory $11.5 M for nano cardiology research
7. Emory scientist finds different paths lead to similar cognitive abilities
8. Emory study finds monarch health tied to migration
9. Emory researchers find more evidence for childrens growth spurts, pain
10. Emory biochemist writes lead essay describing Nobel Prize research on ubiquitin protein
11. Emory study details dolphin brain evolution for the first time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 15, 2019 , ... ... exclusively for Life Sciences and Healthcare companies, announces the availability of new specialty ... and strategic direction to start-up and emerging bio-pharma companies interested in achieving specific ...
(Date:7/9/2019)... ... 2019 , ... Murrieta Genomics, a launch pad for genomic ... and CEO of Tx Genetic, Helen Harrison, has spent several years researching and ... tissue disorders. , “We are pleased and excited to join the growing health ...
(Date:6/25/2019)... ... June 25, 2019 , ... ActX ... raw data, easily available from 23andMe, customers can get access to professionally reviewed ... available for both 23andMe Ancestry and Health + Ancestry customers., With the ActX ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/6/2019)... , ... June 05, 2019 , ... WCCT Global, ... medical device industries, announced today that they will be receiving 3 awards at the ... CA. WCCT received 2 awards in the categories of overall Quality and Compatibility (Access ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study released today in ... for the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) ... deliver CM into the injured kidney, where it helped restore function and regenerate ...
(Date:5/14/2019)... ... May 13, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; ...
Breaking Biology Technology:
Cached News: